Amazon Bio Discovery uses a library of biological foundational models to design and run antibody research experiments.

NEW YORK--(BUSINESS WIRE)--Massive Bio, a leader in AI-powered cancer clinical trial enrollment, today announced that the company exceeded its goal to onboard 100,000 cancer patients in its platform ...

Today, BioTalent Canada and Propero Learning Systems launched AI Fundamentals for the Bio-economy, a new foundational ...

AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery.

TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and ...

Massive Bio, a global precision oncology company, today announced the publication of a peer-reviewed prospective study in ...

Amazon is extending the reach of its “everything store” into drug R&D with the launch of an artificial intelligence-powered Bio Discovery business. The company has compiled a catalogue of 40-plus ...

The liver is an incredibly complex organ, critical for processing toxins and synthesizing 3,000 proteins and other molecules. It’s also one that’s in great demand by thousands of people needing a ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. There’s more to life than protein folding. You’d be forgiven for believing ...